Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Taiho starts phase I trial of TAS-303 in women with stress urinary incontinence

Nov. 3, 2015

Revive Therapeutics' bucillamine receives orphan drug designation for cystinuria

Oct. 30, 2015

Researchers devise mouse model of nocturnal polyuria

Oct. 26, 2015

AF-219 improves symptoms in patients with interstitial cystitis/bladder pain syndrome

Oct. 26, 2015

Cinryze receives FDA fast track designation

Oct. 14, 2015

Astellas Pharma describes prostanoid EP4 antagonists

Oct. 14, 2015

New financing round at Pharmalink to fund development of phase III program for Nefecon

Oct. 6, 2015

Fexeric approved in Europe for hyperphosphatemia in patients with chronic kidney disease

Sep. 25, 2015

NecroX-7 reduces renal ischemia-reperfusion injury in vivo

Sep. 17, 2015

Topline phase II data on GKT-137831 support development in fibrotic diseases

Sep. 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.